{"1707.TW": {"short_name": "GRAPE KING BIO LTD", "long_name": "Grape King Bio Ltd", "summary": "Grape King Bio Ltd produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan, China, and internationally. It operates through Multi-Level Marketing, Distributors, and Original Equipment Manufacturer (OEM) segments. The company offers mushroom mycelium products, such as ganoderma lucidum, agaricus blazei, antrodia cinnamomea, cordyceps sinensis, and coriolus versicolor; probiotics, including enterococcus, bifidobacterium, lactobacillus, pediococcus, streptococcus, saccharomyces, and clostridium; and enzymes. It also provides OEM, original design manufacturing, formulation design, research and development, and raw material supply services. The company was founded in 1969 and is headquartered in Taoyuan, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Drug Manufacturers\u2014Specialty & Generic", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taoyuan City"}, "1731.TW": {"short_name": "MAYWUFA CO", "long_name": "Maywufa Company Ltd.", "summary": "Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. It offers hair color creams; health care products and food supplements; and mother and baby skin care products under the mustela brand. The company also provides pharmaceuticals and medical devices, such as Lyophilized injection; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; and bio-three tablets for the treatment of mild diarrhea, abdominal pain, and constipation. In addition, it sells and distributes pharmaceutical products; and operates and manages pharmacy chain under the Pharmacy Franchise name. The company was founded in 1976 and is headquartered in Taipei City, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Drug Manufacturers\u2014Specialty & Generic", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taipei"}, "1734.TW": {"short_name": "SINPHAR PHARMACEUTICAL CO LTD", "long_name": "Sinphar Pharmaceutical Co.,Ltd.", "summary": "Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan and internationally. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powder and canned special nutrient products. The company also provides shampoo, body wash, tonic water, lotions, moisturizers, sunscreen lotions, and serums; and pharmaceutical packaging products, such as eye drop bottles, dry canisters, tablet bottles, and various medical grade plastic containers. In addition, it offers plant extracts and functional foods; and OEM services, such as product design, manufacturing, etc. to manufacturers. Sinphar Pharmaceutical Co.,Ltd. was founded in 1977 and is headquartered in Yilan, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Yilan City"}, "1760.TW": {"short_name": "PANION & BF BIOTECH INC", "long_name": "Panion & Bf Biotech Inc.", "summary": "Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. The company offers products in the areas of medical beauty, kidney, respiratory tract, gastrointestinal tract, diagnosis, and delayed aging. It also provides oral drugs and external preparations; hand and mechanical disinfection, body lotion, and skin disinfection products; and pet health products, including surgical and skin prescriptions. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei City, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taipei"}, "1783.TW": {"short_name": "MAXIGEN BIOTECH INC", "long_name": "Maxigen Biotech Inc.", "summary": "Maxigen Biotech Inc. engages in the development, manufacture, and marketing of biomedical and skincare products in Taiwan and internationally. The company offers Formagraft, a bone graft substitute; Formasetin, a bone void filler; and intra-articular injections under the ArtiAid, ArtiAid Plus, and ArtiBest names for use in orthopedic area. It also provides Foramic, a bone substitute granule; MaxiBone, a calcium phosphate ceramic; and GingivAid, a collagen dental grafts for use in orthopedic and dental areas. In addition, the company offers FormaAid, a collagen membrane; and E-TECH DENTISTAR II sterilizer and disinfectant for use in dental area, as well as HealiAid, a collagen wound dressing product for use in dental and wound dressing area. Further, it provides ophthalmic viscoelastic device under the ViscAid, PreviscAid, and BiVisc names; and Formaderm, a dermal filler injection for use in plastic surgery. Additionally, the company offers skincare products, including face, neck, body, limbs, and other masks; and make up remover, cleansing, exfoliating, toner, essence, men's care, sunscreen, body care, hand/foot care, and special care products. Maxigen Biotech Inc. was founded in 1998 and is based in Taoyuan City, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taoyuan City"}, "1786.TW": {"short_name": "SCIVISION BIOTECH INC", "long_name": "SciVision Biotech Inc.", "summary": "SciVision Biotech Inc. manufactures and sells hyaluronic acid products in Taiwan. The company offers medical devices, including absorbable adhesion barriers, dermal implants, synovial fluid supplements, and intravesical instillations. SciVision Biotech Inc. was founded in 2001 and is based in Kaohsiung, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Kaohsiung"}, "1789.TW": {"short_name": "SCINOPHARM TAIWAN LTD", "long_name": "ScinoPharm Taiwan, Ltd.", "summary": "ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells CGMP active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. The company offers custom synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; and outsourcing services. It also provides CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates. In addition, the company develops peptide synthesis technologies. Further, it develops and manufactures western medicines and other chemical materials, albumin medicines, oligonucleotide medicines, injections, and new small molecule drugs, as well as provides biological technology services and technical services. The company has a strategic alliance with Baxter International Inc. to develop, manufacture, and commercialize of antiemetic drug in chemotherapy for cancer. ScinoPharm Taiwan, Ltd. was founded in 1997 and is headquartered in Tainan, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Drug Manufacturers\u2014Specialty & Generic", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Tainan City"}, "1795.TW": {"short_name": "LOTUS PHARMACEUTICAL CO", "long_name": "Lotus Pharmaceutical Co., Ltd.", "summary": "Lotus Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells medicines in Taiwan, Korea, the United States, and internationally. Its product portfolio focuses on generics in the fields of oncology, cardiology, nephrology, and central nervous system disease. The company also sells and markets a portfolio of over-the-counter medicines. In addition, it engages in wholesale of cosmetics; retail of clinical machines; biotech technological services; and related consulting services. Lotus Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Taipei City, Taiwan. Lotus Pharmaceutical Co., Ltd. is a subsidiary of Alvogen Emerging Markets Holdings Limited.", "currency": "TWD", "sector": "Healthcare", "industry": "Drug Manufacturers\u2014Specialty & Generic", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taipei"}, "3054.TW": {"short_name": "LIWANLI INNOVATION CO LTD", "long_name": "LIWANLI Innovation Co., Ltd.", "summary": "LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. The company provides products in the areas of nutrition and healthcare. It offers Vigoway and powder collection products for male, female, elderly, and children audience. The company was formerly known as Carry Technology International Co., Ltd. and changed its name to LIWANLI Innovation Co., Ltd. in 2015. LIWANLI Innovation Co., Ltd. was founded in 1991 and is based in New Taipei City, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Drug Manufacturers\u2014Specialty & Generic", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "New Taipei City"}, "3164.TW": {"short_name": "GENMONT BIOTECH INC", "long_name": "GenMont Biotech Incorporation", "summary": "GenMont Biotech Incorporation engages in the research, development, and production of functional probiotics in Taiwan. The company offers functional probiotic raw materials and finished products. It also provides probiotics with special functions; and original formula design and manufacturing, and equipment manufacturing services on health care food, as well as cooperates in the research, production, and clinical trial of various products. GenMont Biotech Incorporation was founded in 2000 and is headquartered in Tainan, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Tainan City"}, "3705.TW": {"short_name": "YUNGSHIN GLOBAL HOLDING CORPORA", "long_name": "YungShin Global Holding Corporation", "summary": "YungShin Global Holding Corporation, through its subsidiaries, produces and sells pharmaceutical products. The company offers medicines and feed additives for swine, ruminants, poultry, pets, and aquatics; APIs, API intermediates, and specialty chemicals, as well as CRO and CMO services; herbal products; health foods; and beauty care products. It also operates EYES testing laboratories for food safety testing; and offers western medicines, agricultural products, chemical intermediates, and over-the-counter medicines. In addition, the company imports and exports pharmaceuticals, APIs, bio-products, and functional food materials; exports medicine-manufacturing machines and components, and medicine/food ingredients, as well as related materials, such as ampoules and vials; imports tablet-analysis equipment; and operates a nursing home for senior care. It operates in Taiwan, China, the United States, Japan, Malaysia, Hong Kong, Singapore, Thailand, Indonesia, Cambodia, and South Africa. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Drug Manufacturers\u2014Specialty & Generic", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taipei"}, "4108.TW": {"short_name": "PHYTOHEALTH CORP.", "long_name": "PhytoHealth Corporation", "summary": "PhytoHealth Corporation engages in the development of botanical drugs in Asia. Its products include PG2 Lyophilized injection, an injectable drug for the treatment of cancer; EnerCharge, which is used in enhancing physical strength, maintaining good spirits, and enhancing health maintenance activities; NatoCleanse capsules, which helps to reduce the risk of cardiovascular diseases; ReyeasCleanse health food capsules; and EnerCharge, an energy drink. The company was founded in 1998 and is based in Taipei, Taiwan. PhytoHealth Corporation is a subsidiary of Maywufa Company Ltd.", "currency": "TWD", "sector": "Healthcare", "industry": "Drug Manufacturers\u2014Specialty & Generic", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taipei"}, "4133.TW": {"short_name": "ABNOVA (TAIWAN) CORPORATION", "long_name": "Abnova (Taiwan) Corporation", "summary": "Abnova (Taiwan) Corporation manufactures and sells various recombinant proteins and antibodies. It offers DNA and RNA, proteins/peptides, beads/dyes, lysates/slides, antibody pairs/kits, antibody and tissue arrays, in situ hydridization products, circulating rare cells, systems and automations, GMP and analyte specific reagents, and in vitro diagnostics. The company also provides MaxPab, monoclonal, polyclonal, recombinant, conjugate, secondary/tag, and IHC/pathology antibodies. In addition, the company's integrated solutions and services include gene synthesis and cytogenetics; peptide, protein expression, and conjugations; antibody production; and assay development services. Abnova (Taiwan) Corporation is headquartered in Taipei, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taipei"}, "4142.TW": {"short_name": "ADIMMUNE CORPORATION", "long_name": "Adimmune Corporation", "summary": "Adimmune Corporation manufactures and sells human vaccines in Taiwan. It offers AdimFlu-S, an influenza vaccine; tetanus toxoid alum precipitated products used for prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent and Tetravalent influenza vaccines; Influenza A (H1N1) virus monovalent vaccines; and Tuberculin, as well as contract manufacturing services. The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001. Adimmune Corporation was founded in 1965 and is based in Taichung City, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taichung"}, "4737.TW": {"short_name": "BIONIME CORPORATION", "long_name": "Bionime Corporation", "summary": "Bionime Corporation manufactures and sells medical instruments in Algeria, the United States, Switzerland, China, and internationally. It offers medical testing blood glucose management products for self-monitor and hospital/clinic use, as well as accessories, such as test strips and lancing devices. The company was founded in 2003 and is headquartered in Taichung, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taichung"}, "4746.TW": {"short_name": "FORMOSA LABORATORIES INC", "long_name": "Formosa Laboratories, Inc.", "summary": "Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) and UV-filters worldwide. Its API products include vitamin D derivatives, balsalazide, benzonatate, capsaicin, colesevelam, gadodiamide, flupentixol, melitracen, meprobamate, montelukast, mycophenolate mofetil, sevelamer, and taltirelin covering the areas of anticancers, anti-inflammatory and analgesic agents, MRI enhancing agents, polymeric drugs, CNS agents, immunomodulators, respiratory agents, steroids, vit. D derivatives, and antibiotics. The company also provides UV filters, such as avobenzone and octinoxate. In addition, it offers custom synthesis service ranging from process development to commercial production for APIs and other specialty chemicals; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Drug Manufacturers\u2014Specialty & Generic", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taoyuan City"}, "546.SI": {"short_name": "$ Medtecs Intl", "long_name": "Medtecs International Corporation Limited", "summary": "Medtecs International Corporation Limited, an integrated healthcare products and services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups worldwide. It operates through Manufacturing, Hospital Services, and Distribution segments. The Manufacturing segment produces and sub-contracts a range of medical consumables, including patients' apparels, disposable surgical masks, boot covers and surgical gowns, underpads, adult diapers, crochet blankets, bed linens, and medical bandages. The Hospital Services segment provides laundry and leasing services, including hospital linen rental and laundry, management of hospital laundry facilities, hospital automation, and other non-core hospital functions for hospitals in Taiwan and the Philippines. The Distribution segment markets Medtecs-branded medical consumables to hospitals, pharmacies, and other end users in the Asia Pacific. This segment also supplies other branded medical supplies and equipment comprising wheel chairs, syringes, nebulizers, and blood pressure monitors. Medtecs International Corporation Limited also manufactures, leases, trades in, and sells woven and knitted fabrics, and other made-up articles of textile products; trades in hospital textiles and garments, pillow cases, bed sheets, gowns, and other apparel products; and provides garters and other garment products. It also engages in the subleasing activities; and manufacture and supply personal protective equipment. The company was founded in 1989 and is headquartered in Taipei, Taiwan.", "currency": "SGD", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "SES", "market": "sg_market", "country": "Taiwan", "city": "Taipei"}, "6491.TW": {"short_name": "PEGAVISION CORPORATION", "long_name": "Pegavision Corporation", "summary": "Pegavision Corporation manufactures and sells various soft contact lenses, medical optic devices, and precision instruments under the Pegavision brand in Taiwan. It also operates as an OEM for customers internationally. The company was founded in 2009 and is headquartered in Taoyuan City, Taiwan. Pegavision Corporation is a subsidiary of Kinsus Interconnect Technology Corp.", "currency": "TWD", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taoyuan City"}, "6ZD.F": {"short_name": "ONENESS B.GDR REGS/5 TA10", "long_name": "Oneness Biotech Co., Ltd.", "summary": "Oneness Biotech Co., Ltd. operates as a biopharmaceutical company in Taiwan. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers; and OB318, an anti- liver cancer drug that completed Phase I clinical trials. It is also developing SNS01, SNA02, and SNA03 that are in pre-clinical stage for the treatment of cancer; FB704A that is in Phase I clinical trial for the treatment of rheumatoid arthritis, cancer, and cytokine storms; and FB825, which is in Phase II clinical trial for treating allergic diseases and asthma. The company was founded in 2008 and is based in Taipei City, Taiwan. Oneness Biotech Co., Ltd. operates as a subsidiary of Microbio Co., Ltd.", "currency": "EUR", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "FRA", "market": "dr_market", "country": "Taiwan", "city": "Taipei"}, "7TLA.F": {"short_name": "TAIWAN LIPOSOME SP.ADR/2", "long_name": "Taiwan Liposome Company, Ltd.", "summary": "Taiwan Liposome Company, Ltd., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). Its BioSeizer lipid formulation technology enables pharmacokinetic (PK) control and local sustained release of APIs at the site of disease or injury; and NanoX active drug loading technology enables the potential for reduced dosing frequency and enhanced distribution of liposome-encapsulated APIs to the desired site. The company provides various product candidates that target various areas of unmet medical need in pain management, ophthalmology, and oncology. Its lead product candidate is TLC599, an intraarticular injectable BioSeizer formulation of the API steroid dexamethasone sodium phosphate (DSP), which is in Phase III trial for knee osteoarthritis pain. The company's product candidates also comprises TLC590, a non-opioid BioSeizer formulation of the API ropivacaine that is in Phase II clinical trial for post-surgical pain management; TLC399, a multilamellar and multivesicular BioSeizer formulation of DSP, which is in Phase II clinical trial for ophthalmology indications; and TLC178, an API that is in Phase I/II dose escalation trial to treat rhabdomyosarcoma. Taiwan Liposome Company, Ltd. was founded in 1997 and is headquartered in Taipei, Taiwan.", "currency": "EUR", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "FRA", "market": "dr_market", "country": "Taiwan", "city": "Taipei"}, "9103.TW": {"short_name": "MEDTECS INTERNATIONAL CORP", "long_name": "Medtecs International Corporation Limited", "summary": "Medtecs International Corporation Limited, an integrated healthcare products and services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups worldwide. It operates through Manufacturing, Hospital Services, and Distribution segments. The Manufacturing segment produces and sub-contracts a range of medical consumables, including patients' apparels, disposable surgical masks, boot covers and surgical gowns, underpads, adult diapers, crochet blankets, bed linens, and medical bandages. The Hospital Services segment provides laundry and leasing services, including hospital linen rental and laundry, management of hospital laundry facilities, hospital automation, and other non-core hospital functions for hospitals in Taiwan and the Philippines. The Distribution segment markets Medtecs-branded medical consumables to hospitals, pharmacies, and other end users in the Asia Pacific. This segment also supplies other branded medical supplies and equipment comprising wheel chairs, syringes, nebulizers, and blood pressure monitors. Medtecs International Corporation Limited also manufactures, leases, trades in, and sells woven and knitted fabrics, and other made-up articles of textile products; trades in hospital textiles and garments, pillow cases, bed sheets, gowns, and other apparel products; and provides garters and other garment products. It also engages in the subleasing activities; and manufacture and supply personal protective equipment. The company was founded in 1989 and is headquartered in Taipei, Taiwan.", "currency": "TWD", "sector": "Healthcare", "industry": "Medical Instruments & Supplies", "exchange": "TAI", "market": "tw_market", "country": "Taiwan", "city": "Taipei"}, "TLC": {"short_name": "Taiwan Liposome Company, Ltd.", "long_name": "Taiwan Liposome Company, Ltd.", "summary": "Taiwan Liposome Company, Ltd., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). Its BioSeizer lipid formulation technology enables pharmacokinetic (PK) control and local sustained release of APIs at the site of disease or injury; and NanoX active drug loading technology enables the potential for reduced dosing frequency and enhanced distribution of liposome-encapsulated APIs to the desired site. The company provides various product candidates that target various areas of unmet medical need in pain management, ophthalmology, and oncology. Its lead product candidate is TLC599, an intraarticular injectable BioSeizer formulation of the API steroid dexamethasone sodium phosphate (DSP), which is in Phase III trial for knee osteoarthritis pain. The company's product candidates also comprises TLC590, a non-opioid BioSeizer formulation of the API ropivacaine that is in Phase II clinical trial for post-surgical pain management; TLC399, a multilamellar and multivesicular BioSeizer formulation of DSP, which is in Phase II clinical trial for ophthalmology indications; and TLC178, an API that is in Phase I/II dose escalation trial to treat rhabdomyosarcoma. Taiwan Liposome Company, Ltd. was founded in 1997 and is headquartered in Taipei, Taiwan.", "currency": "USD", "sector": "Healthcare", "industry": "Biotechnology", "exchange": "NGM", "market": "us_market", "country": "Taiwan", "city": "Taipei"}}